| Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
|---|
| 03/19/2008 | CN101146786A Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase |
| 03/19/2008 | CN101146760A Intermediate in production of [2-(3,3,5,5-tetramethylcyclohexyl)phenyl]piperazine compound |
| 03/19/2008 | CN101143857A Benzoyl guanidine derivative, preparation method and medical use thereof |
| 03/18/2008 | US7345168 reacting diphosphorus pentoxide, an organic base (melamine, guanidine, piperazine), and a water releasing agent (borax, aluminum or magnesium hydroxide, or oxalic or formic acid) to form polyphosphate salts; fire retardants for thermoplastic polyamide or polyester platics |
| 03/18/2008 | US7345095 Alpha, beta -peptide inhibitors; Alzheimer's disease; 2-(4-Chloro-benzenesulfonylamino)-3-phenyl-propionic acid methyl ester |
| 03/18/2008 | CA2266781C Piperazine based cytofectins |
| 03/13/2008 | WO2008029810A1 Phenylguanidine derivative or salt thereof, and pest control agent containing them as active ingredient |
| 03/13/2008 | US20080064873 Oxidizing an amino alcohol (obtained by ring opening the epoxy, aziding, reducing and reacting it with a carboxylic acid); stereoselectivity; protease inhibitors: antiallergens; anticarcinogenic and hypotensive agents |
| 03/13/2008 | US20080064690 Neuropathic or inflammatory pain relief; inhibiting ion flux through channel including PN3 subunit; potency |
| 03/13/2008 | US20080064687 Vanilloid receptor modulators; analgesic, antiinflammatory and antiulcer effects; such as 1-(1H-indol-5-ylmethyl)-3-phenethylthiourea |
| 03/13/2008 | US20080064684 Sub-type selective serotonin receptor agonists; antidepressants; schizophrenia, Alzheimer's Disease, Parkinson's Disease; alkylation or amidation of the heterocyclylbenzazole with an alkylhalide or acylhalide |
| 03/12/2008 | EP1897864A1 Anthracene derivatives and the use thereof for treating benign and malignant tumors |
| 03/12/2008 | EP1896447A2 Methods and intermediates for the preparation of optionally radio-labeled imatinib |
| 03/12/2008 | EP1495009B1 Cyanamides useful as reversible inhibitors of cysteine proteases |
| 03/12/2008 | EP1494654B1 Palatable chewable tablet |
| 03/12/2008 | CN101142201A Substituted phenyl-piperazine compounds, their preparation and use in medicaments |
| 03/12/2008 | CN101142200A Addition salts of tolperisone, processes for their preparation and use thereof |
| 03/12/2008 | CN101139304A Conjugated dienamides and uses thereof |
| 03/11/2008 | US7342020 Effective against MMP 9 and 13; arthritis, atherosclerosis; synthesis |
| 03/11/2008 | US7342018 Urokinase inhibitors and uses thereof |
| 03/11/2008 | US7341715 Method and agents on the basis of 2-mercaptopropionic acid amides for durable hair forming and a method for producing same |
| 03/11/2008 | CA2293382C Piperazine derivatives and their use as anti-inflammatory agents |
| 03/06/2008 | WO2008005846A3 Methods, mixtures, kits and compositions pertaining to analyte determination |
| 03/06/2008 | WO2007131201A3 Compounds and compositions as hedgehog pathway modulators |
| 03/06/2008 | WO2007000641A8 Prostaglandin derivatives |
| 03/06/2008 | US20080058543 Process for making chiral 1,4-disubstituted piperazines |
| 03/06/2008 | US20080058516 Epoxycarboxamide compound, azide compound, and amino alcohol compound, and process for preparing alpha-keto amide compound using them |
| 03/06/2008 | US20080058514 ceramide-like inhibitors; novel intermediates formed during the synthesis; Glycosphingolipids |
| 03/06/2008 | US20080058383 Such as 2-methyl-2-(4-nitro-3-trifluoromethyl-phenylamino)-propan-1-ol; prostate cancer; cardiovascular disorders; psychological disorders |
| 03/06/2008 | US20080058377 N-(7-hydroxy-5,6,7,8-tetrahydronaphthalen-2-yl)-N'-[4-(trifluoromethyl)benzyl] urea; antiinflammatory agent: asthma or COPD, analgesic: neuralgia, neuropathies, algesia, nerve injury, ischemia, neurodegeneration, or stroke; urological diseases: urinary incontinence or overactive bladder |
| 03/06/2008 | US20080058346 Crystalline Modifications of N-Alpha-(2,4,6-Triisopropylphenylsulfonyl)-3-Hydroxyamidino- (L)- Phenylalanine 4-Ethoxycarbonylpiperazide And/Or Salts Thereof |
| 03/06/2008 | US20080058340 MEK kinase (mitogen-activated ERK-activating kinases or MAP kinase kinase); cancer, tumors, infections, autoimmune disorders, stroke, ischemia, rheumatoid arthritis, multiple sclerosis, psoriasis, restenosis; 1-sulfonamido-2-(phenylamino)-4-fluorobenzene compounds |
| 03/06/2008 | US20080058336 Secretase inhibitor |
| 03/06/2008 | US20080058335 Pain, inflammatory or immune disorders, neurological disorders, cancers of the immune system, respiratory disorders, cardiovascular disorders, neuroprotection; e.g. 5-chloro-N-[(2Z)-5-(1-hydroxy-1-methylethyl)-3-[((cis)-3-methoxycyclobutyl)methyl]-4-methyl-1,3-thiazol-2(3H)-ylidene]-2-methoxybenzamide |
| 03/06/2008 | US20080058333 Carbamates such as (1-benzylcyclohexyl)methyl(1S)-5-[(4-morpholinylcarbonyl)amino]-1-(oxo([(1R)-1-phenylethyl]amino)acetyl)pentylcarbamate; osteoporosis |
| 03/06/2008 | US20080058331 Inhibitors for GlyT-1 |
| 03/06/2008 | US20080058329 Novel indane compounds |
| 03/06/2008 | US20080058323 Therapy of vascular system diseases |
| 03/06/2008 | US20080058314 Novel dicarboxylic acid derivatives with pharmaceutical properties |
| 03/06/2008 | US20080058311 Antagonizing N-type calcium channels; use as analgesic, neurodegenerative diseases, brain injury, bronchial asthma, unstable angina and irritable colitis, drug withdrawal symptoms; t-butyl 2-[4-(5H-dibenzo[a,d][7]annulen-5-ylidene)-1-piperidinyl]-2-oxoethylcarbamate for example |
| 03/06/2008 | US20080058297 Heterocyclic Compounds For Preventing And Treating Disorders Associated With Excessive Bone Loss |
| 03/06/2008 | US20080058290 Substituted Phenoxy-and Phenylthio-Derivatives for Treating Proliferative Disorders |
| 03/06/2008 | US20080056991 Histamine H3 receptor inhibitors; (4-Azepan-1-ylmethyl-phenyl)-(4-isopropyl-piperazin-1-yl)-methanone dihydrochloride for example; allergies, nasal congestion, eating disorders, sleep disorders, neurodegenerative disorders |
| 03/06/2008 | US20080056987 Inhibitor of Eph receptor kinase; treat angiogenesis, lymphangiogenesis or asculogenesis, disorder of the blood vessels, hyperproliferation of body cells, chronic or acute neurodegenerative disorder; enteral, parenteral and oral administration |
| 03/05/2008 | EP1893566A1 Cyclohexanesulfonyl derivatives as glyt1 inhibitors to treat schizophrenia |
| 03/05/2008 | EP1893210A2 Selective apoptotic induction in cancer cells including activation of procaspase-3 |
| 03/05/2008 | CN101137650A 2-[(isoquinolin-3-carbonyl)amino]-propionic acid derivatives as inhibitors of factors xi and ix for the treatment of thrombosis |
| 03/05/2008 | CN101137636A Exo-selective synthesis of himbacine analogs |
| 03/05/2008 | CN101137633A Process for the preparation of 1-aminopiperidine derivatives |
| 03/05/2008 | CN101137632A Process for making trans-1-((1r,3s)-6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine |
| 03/04/2008 | US7338978 Insecticidal anthranilamides |
| 03/04/2008 | US7338952 N-[2-[4-[(4-chlorophenyl)ethynyl]-2-methylphenoxy]-1-methylethyl]-1,4-benzenedimethanamine; phosphorylation, polymorphonuclear leukocyte, macrophage, lipopolysaccharide, tumor necrosis factor- alpha, cytokine IFN- gamma, interleukin-2 mediated disorders ; arthritis, osteoarthritis, Alzheimer's disease |
| 02/28/2008 | WO2008023720A1 Urea compound or salt thereof |
| 02/28/2008 | WO2008022541A1 Water-soluble derivatives of anesthetic 2,6-diisopropylphenol and preparation method thereof |
| 02/28/2008 | WO2007054836A3 1, 2-substituted naphthalene derivatives with antiglutamatergic properties and uses thereof |
| 02/28/2008 | WO2007016136A3 Organic nitric oxide enhancing salts of cyclooxygenase-2 selective inhibitors, compositons and methods of use |
| 02/28/2008 | US20080051434 Hemiasterlin derivatives and uses thereof in the treatment of cancer |
| 02/28/2008 | US20080051416 Novel Compounds |
| 02/28/2008 | US20080051409 Indolizine Carboxamides and Aza and Diaza Derivatives Thereof |
| 02/28/2008 | US20080050657 Quaternary Ammonium Salt, Electrolyte, Electrolyte, Solution and Electrochemical Device |
| 02/28/2008 | CA2665804A1 Urea compound or salt thereof |
| 02/28/2008 | CA2661401A1 Cyclic 11-beta hydroxysteroid dehydrogenase type i inhibitors |
| 02/27/2008 | EP1891065A1 Novel mchr1 antagonists and their use for the treatment of mchr1 mediated conditions and disorders |
| 02/27/2008 | EP1891029A1 Organic compounds for the treatment of imflammatory or alleric conditions |
| 02/27/2008 | EP1891028A1 Non-peptidic inhibitors of akap/pka interaction |
| 02/27/2008 | EP1890697A2 Azinone and diazinone v3 inhibitors for depression and stress disorders |
| 02/27/2008 | EP1740530A4 Substituted phenoxy- and phenylthio- derivatives for treating proliferative disorders |
| 02/27/2008 | EP1615904B1 Substituted benzosulphonamides as potentiators of glutamate receptors |
| 02/27/2008 | EP1446115B1 Cyanoalkylamino derivatives as protease inhibitors |
| 02/27/2008 | EP1248612B1 Novel compounds and compositions as protease inhibitors |
| 02/27/2008 | CN101133060A Enzyme inhibitors |
| 02/27/2008 | CN101133042A Nitro-substituted phenyl-piperazine compounds, their preparation and use in medicaments |
| 02/27/2008 | CN101133041A Piperazino based multi-functional photoinitiators |
| 02/27/2008 | CN101133030A Menthane carboxamide derivatives having cooling properties |
| 02/27/2008 | CN101130527A Sulfonic group functionalized morpholine quaternary ammonium salt ionic liquid and method for preparing the same |
| 02/27/2008 | CN100371333C Method for producing marpholine and monoethylamine using by-products N-ethylamine from morpholine prodn. installation as raw material |
| 02/27/2008 | CN100371318C Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases |
| 02/26/2008 | US7335788 S-(α, α′-disubstituted-α″-acetic acid) substituted dithiocarbonate derivatives for controlled radical polymerizations, process and polymers made therefrom |
| 02/26/2008 | US7335781 perform as superior catalysts in asymmetric addition reactions wherein organic zinc and aldehyde are involved; Such catalyses are economically useful for industries |
| 02/26/2008 | US7335687 Used to treat hypercholesterolemia, hyperlipemia, arteriosclerosis, mycoses, gallstones, hyperproliferative disorders, impaired glucose tolerance, or diabetes; aminocyclohexanol derivatives; e.g. N-(4-(4-[ethyl-(2-hydroxy-ethyl)-amino]-but-1-ynyl)-cyclohexyl)-N-methyl-4-trifluoromethyl-benzenesulfonamide |
| 02/26/2008 | US7335681 Inhibit glucosyl ceramide (GlcCer) formation by inhibiting the enzyme GlcCer synthase; Gaucher's disease, Tay Sachs disease, Fabry's disease. Sandhoff disease or GM1 gangliosidosis |
| 02/26/2008 | US7335677 Inhibitors of dipeptidyl peptidase IV |
| 02/26/2008 | US7335673 2,3-Diphenylpropionic acid derivatives or their salts, medicines or cell adhesion inhibitors containing the same, and their usage |
| 02/26/2008 | US7335659 Substituted 10-aryl-11H-benzo[b]fluorenes and 7-aryl-5, 6-dihydro-benzo[a]anthracenes for selective effects on estrogen receptors |
| 02/21/2008 | WO2007103456A3 Piperazine and piperidine biaryl derivatives |
| 02/21/2008 | US20080045708 New Process for the Synthesis of Morpholinylbenzenes |
| 02/21/2008 | US20080045620 Piperazino Based Photoinitiators |
| 02/21/2008 | US20080045543 6-(2-Benzyl-piperazin-1-yl)-1H-indole, used as serotonin, norepinephrine or dopamine reuptake inhibitors; antidepressants; anxiolytic agents; monoamine reuptake inhibitors |
| 02/21/2008 | US20080045534 Derivatives of 1,3-diamino benzene as potassium channel modulators |
| 02/21/2008 | US20080045533 Novel cyclohexyl sulphones |
| 02/21/2008 | US20080045529 Use Of Thienopyrimidines |
| 02/21/2008 | US20080045522 Omega-aminoalkylamides of r-2-aryl-propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells |
| 02/21/2008 | US20080045517 Such as {(2S)-2-[2-[2-(7-azabicyclo[2.2.1]hept-7-yl)-1,1-dimethyl-2-oxoethyl]-5-(3,5-dimethylphenyl)-6H-thieno[2,3-b]pyrrol-4-yl]propyl}(2-pyridin-4-ylethyl)amine for treating sex hormone related prostate cancer and pre-menopausal breast cancer |
| 02/21/2008 | US20080045509 Substituted benzyl amine compounds |
| 02/21/2008 | US20080045507 Substituted benzamide modulators of the histamine h3 receptor |
| 02/21/2008 | US20080045504 Benzonitrile Derivatives to Treat Musculoskeletal Frailty |
| 02/21/2008 | US20080045492 Mitotic Kinesin Inhibitors |
| 02/21/2008 | US20080044379 (1R)-2-((2S)-2-(5-(6-(4-(2-((2S)-1-((2R)-2-(dimethylamino)-2-phenylacetyl)-2-pyrrolidinyl)-1H-imidazol-5-yl)phenyl)-3-pyridinyl)-1H-imidazol-2-yl)-1-pyrrolidinyl) -N,N-dimethyl-2-oxo-1-phenylethanamine; inhibit the function of the non-structural proteins (NS5A) |
| 02/21/2008 | DE102006039003A1 Neue Verbindungen New connections |
| 02/21/2008 | CA2660911A1 Thiourea compounds |